Effects of Static Stretching and Dynamic in Flexibility and Performance: Blind and Randomized Clinical Trial
NCT ID: NCT02689544
Last Updated: 2016-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2015-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study hypothesis:
1. Static stretching program improves flexibility and reduces neuromuscular and functional performance in active, healthy individuals.
2. Static stretching program improves flexibility and neuromuscular and functional performance in active, healthy individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electromyographic Responses by Static Stretching and Neural Mobilization
NCT01379105
Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion
NCT07213011
Acute Effects of Gastrocnemius Myofascial Release on Cervical Flexion and Extension Range of Motion in Healthy Adults
NCT07025746
Remote Effects of Lower Limb Stretching
NCT02564081
Examining The Effects of Core Stabilization Exercises and Myofascial Release Technique in Individuals With Chronic Neck Pain: A Randomized Clinical Trial
NCT06352294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sample size calculation
For the sample size calculation was used G \* Power 3.1.0 software and the procedures followed the recommendations of studies prévios45. Based on a pilot study of four volunteers, it has adopted a power of 0.95, considering a significance level of 5%, a correlation coefficient of 0.5, and 0.25 effect size for both, It calculated a "n" sample of 15 individuals for each group ("n" sample = 45). This analysis was performed to reduce the chance of Type II error and to determine the minimum number of individuals required for this investigation. Thus, the sample size was sufficient to provide 95.5% statistical power.
Procedures and evaluation measures
At first all subjects were recorded in the survey through an evaluation form containing information on identification, weight, height, injury history and physical activity .
After the process of randomization and allocation held by P2, the volunteers underwent the first evaluation (AV1) under the instruction of P1. This evaluation was performed at least 48 hours before the 1st stretching session to prevent possible residual effects of isokinetic and functional testing. Other evaluations AV2, AV3 and AV4, were made immediately after the 1st (acute response) and 10th sessions (acute post elongation) and 48 hours after the last (residual chronic response), respectively, for EAG and GAD. Already the subject of gc were subject only to the four evaluation processes, where the last assessment (AV4) coincided with the time related to the stretching protocol of the experimental groups. Despite receiving the same guidelines of the other groups on the importance of stretching activities routines during the study period the volunteers were told they should not perform stretching in the day-to-day.
All had non-dominant leg (MND) tested for flexibility, neuromuscular performance (muscle latency time and isokinetic performance) and functional performance (functional tests) in all four assessments. The MND was used because it is considered less skilled and more trainable, when compared to the MD46. For their identification was asked which member preferred to kick a bola15. However, during the interventions in the experimental groups (GAE, GAD), both members were elongated, evaluating the pain sensation at the end of each session and at the end of the intervention protocols, sensory perception (pleasure / displeasure) in performing elongation. The day of the period in which prevailed the assessments and reassessments was on afternoon shift.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
static stretching
Group of 15 volunteers (gSS)
intervention with static stretching
Members of static stretching group performed three sets of 30 second self hamstring stretch (IT) of both lower limbs, with 30 seconds of rest between sets, totaling 3 minute intervention so.
dynamic stretching
Group of 15 volunteers (gDS)
intervention with Dynamic Stretching
Each subject contracting antagonist muscle (quadriceps) to the target muscle (hamstring), performing dynamic movements of hip flexion with the knee extended, repeated every 1 second. They amounted to 3 of 30 repetitions completing approximately three minutes of dynamic stretching for each lower.
control
Group of 15 volunteers (gC)
Control
The control group volunteers no received intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intervention with static stretching
Members of static stretching group performed three sets of 30 second self hamstring stretch (IT) of both lower limbs, with 30 seconds of rest between sets, totaling 3 minute intervention so.
intervention with Dynamic Stretching
Each subject contracting antagonist muscle (quadriceps) to the target muscle (hamstring), performing dynamic movements of hip flexion with the knee extended, repeated every 1 second. They amounted to 3 of 30 repetitions completing approximately three minutes of dynamic stretching for each lower.
Control
The control group volunteers no received intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
(2) were aged between 18 and 28 years old;
(3) Body mass index (BMI) of 21 to 25 kg / m2,
(4) not be participating in lower limb stretching programs;
(5) be healthy, according to Physical Activity Readiness Questionnaire (PAR-Q) and perform physical activity (recreational, not competitive level) for at least 3 times a week, according to the International Physical Activity Questionnaire (IPAQ)
(6) no history of injury or disease in the lower limbs in the last six months, without previous surgery in this segment;
(7) lack of musculoskeletal, cardiorespiratory and neurological disorders that prevent the completion of the evaluation and treatment protocols;
(8) is not under the effect of medicines that cause muscle relaxation or that inhibit muscle tonic action
(9) has ROM limitation (degree of muscle shortening) of at least 15 ° of active extension of joelho21, the non-dominant leg (considering 180 the full extent with hip positioned at 90 ° of flexion).
Exclusion Criteria
(2) not perform evaluative and intervention procedures;
(3) absence of at least one of the sessions of stretching protocol;
(4) appearance of lesions during the period in which the subject is inserted in the survey;
(5) withdrawal in the study. Thus, it excluded eight volunteers, three per occurrence of injuries during the study period and five per withdrawal, concluding the study with a total of 45 subjects.
18 Years
28 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Germanna de Medeiros Barbosa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Germanna de Medeiros Barbosa
Federal University of Rio Grande do Norte
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wouber H Vieira, Prof.Dr.
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio Grande do Norte
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.132.671
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.